CNP-Aquaporin 4 (Cour Pharmaceutical)

N/A

Report date: 2025/11/28 11:20:46

Base Information

Drug NameCNP-Aquaporin 4 (Cour Pharmaceutical)
Drug Alias NameCNP-Aquaporin 4 tolerizing immune modifying nanoparticles (Cour Pharmaceutical)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionAquaporins 4 modulators
TargetsAquaporins 4
Therapy Area/IndicationsNeuromyelitis Optica
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCour Pharmaceutical Development Company Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCour Pharmaceutical Development Company Inc
Active IndicationsN/A
Inactive IndicationsNeuromyelitis Optica

Other Information

ATC CodeN/A
Related LinksN/A